Related Experiment Video
Updated: May 6, 2026
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Sinonasal Intestinal-Type Adenocarcinoma in the Netherlands: A Nationwide Study (2008-2022)
Lise J van de Velde1, Gerben E Breimer2, W F Julius Scheurleer1
1Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Background:
Intestinal-type adenocarcinoma (ITAC) is a rare sinonasal malignancy with poor survival. By creating a clinical and epidemiological overview of the Dutch ITAC population between 2008 and 2022, this study aims to identify areas for improvement in ITAC management.
Methods:
A systematic query within the Netherlands Cancer Registry (NCR) was performed to assemble the nationwide ITAC cohort. Incidence calculations were performed alongside overall survival (OS) and relative survival (RS) estimations.
Results:
171 patients were included. Yearly incidence was low (0.04-0.12 per 100 000 person-years) and showed a non-significant, slight upward tendency. The population was predominantly male (92.5%), diagnosed at advanced stages (55% ≥ cT3) and sparsely presented with regional (4.7%) and/or distant metastases (5.9%). The 5-year OS (47.8%, 95% CI: 39.4%-55.6%) and RS (55.5%, 95% CI: 45.8%-64.6%) rates were poor. The addition of radiotherapy to surgery yielded better OS and RS compared to surgery alone.
Conclusion:
ITAC incidence shows a minimal upward tendency in the Netherlands, and survival chances remain poor. Ongoing vigilance in high-risk industries and the further implementation of adjuvant radiotherapy may lead to improved outcomes in the future. Biology-driven research is warranted to additionally tailor treatment strategies.
